Conclusion: Rasagiline is an investigational selective and irreversible inhibitor of MAO-B that has demonstrated efficacy and safety for the treatment of PD. Whether rasagiline is associated with ...

Understanding the structure-activity relationship (SAR) and mechanisms underlying MAO inhibitors is crucial but ... significantly enhanced MAO-B inhibition and increased selectivity for MAO ...

Healthcare providers may prescribe levodopa, dopamine agonists, anticholinergics, catechol-o-methyltransferase (COMT) inhibitors, and type-B monoamine oxidase (MAO-B) inhibitors to manage symptoms.

Understanding the structure-activity relationship (SAR) and mechanisms underlying MAO inhibitors is crucial but ... significantly enhanced MAO-B inhibition and increased selectivity for MAO ...

Hollander, W., Symp. Hypertension, Hahnemann Medical College and Hospital, Philadelphia (Dec. 8–12, 1958). Gertner, S., Paasonen, M., and Giarman, N. J., Fed. Proc ...